Mark Rothera

Chief Executive Officer at VIRACTA THERAPEUTICS, INC.

63 year

Health Technology

Commercial Services

Consumer Services

Profile

Mark A. Rothera is currently Chief Executive Officer at Viracta Therapeutics, Inc., Chief Executive Officer & Director at TreeFrog Therapeutics SAS starting in 2025, Director at Genpharm Services, and President & Director at Orchard Therapeutics North America.
Former roles include President, CEO & Executive Director at Silence Therapeutics Plc from 2020 to 2022; President, Chief Executive Officer & Director at Orchard Therapeutics (Europe) Ltd. from 2017 to 2020; President, CEO & Executive Director at Orchard Therapeutics Plc from 2018 to 2020; Director at Alliance for Regenerative Medicine; Director at INVO Fertility, Inc.; Chief Commercial Officer at PTC Therapeutics, Inc. from 2013 to 2017; Executive VP-Strategy & Business Development at Aegerion Pharmaceuticals, Inc. from 2012 to 2013; President & General Manager-Commercial Operations at Shire Human Genetic Therapies, Inc. from 2006 to 2012; and Vice President-Europe, Middle East & Africa at CHIRON Biopharmaceuticals from 2000 to 2005.
Education includes graduate studies at the University of Cambridge and an MBA from INSEAD.

Mark Rothera active positions

Companies	Position	Start
VIRACTA THERAPEUTICS, INC.	Chief Executive Officer	-
Genpharm Services Genpharm Services Advertising/Marketing ServicesCommercial Services Provides pharmaceutical marketing and consulting services	Director/Board Member	-
Orchard Therapeutics North America Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services	President	-
TreeFrog Therapeutics SAS TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company	Chief Executive Officer	15/12/2025

All active positions of Mark Rothera

Former positions of Mark Rothera

Companies	Position	End
SILENCE THERAPEUTICS PLC	Chief Executive Officer	21/02/2022
Orchard Therapeutics (Europe) Ltd. Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies	Chief Executive Officer	17/03/2020
ORCHARD THERAPEUTICS PLC	Chief Executive Officer	17/03/2020
PTC THERAPEUTICS, INC.	Corporate Officer/Principal	09/08/2017
AEGERION PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2013

See the detail of Mark Rothera's experience

Training of Mark Rothera

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Rothera's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
PTC Therapeutics, Inc. PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases	Health Technology
Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases	Health Technology
Silence Therapeutics Plc Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products	Commercial Services
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
INSEAD INSEAD Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Shire Human Genetic Therapies, Inc. Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies	Health Technology
CHIRON Biopharmaceuticals
Alliance for Regenerative Medicine Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine	Health Services
Genpharm Services Genpharm Services Advertising/Marketing ServicesCommercial Services Provides pharmaceutical marketing and consulting services	Commercial Services
Orchard Therapeutics (Europe) Ltd. Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies	Health Technology
Orchard Therapeutics Plc Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases	Health Technology
TreeFrog Therapeutics SAS TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company	Commercial Services
Orchard Therapeutics North America Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services	Health Technology
Viracta Therapeutics, Inc. Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers	Health Technology